ETO (MTG8) was first described due to its involvement in the (8;21) translo
cation frequently observed in acute myeloid leukemias. In the t(8;21) the A
ML1 gene on chromosome 21 is fused to ETO on chromosome 8. The resultant hy
brid protein is comprised of the DNA, binding domain of AML-1 and the major
ity of ETO. This study examines the subnuclear distributions of ETO, AML-1B
and AML-1/ETO proteins fused to green fluorescence protein in living cells
using fluorescence microscopy. Further, we identified a 40 amino acid port
ion of ETO (amino acids 241-280) that was sufficient to cause nuclear impor
t of green fluorescent protein. Mutational analysis demonstrated that lysin
e 265 and/or arginine 266 were required for nuclear impart of ETO, but that
the surrounding basic residues were not critical, ETO interacted with the
nuclear import proteins importin-alpha and beta in vitro, and mutations in
ETO that abolish nuclear localization also abolished the in vitro interacti
on with importin-alpha and beta. These data suggest that ETO enters the nuc
leus via an importin-mediated pathway. additionally, ETO and AMIL-1/ETO co-
localized to punctate nuclear bodies distinct from those containing promyel
ocytic leukemia protein. Nuclear body formation was dependent upon a region
of ETO N-terminal to the nuclear localization signal. Thus, ETO and AML-1/
ETO reside in potentially novel subnuclear compartments.